Switch to:
More From Other Websites
Could Growing HIV Franchise Drive Gilead Sciences’ Valuation? Sep 30 2016
Regeneron Pharmaceuticals Falls As Combo Therapy Worse Than Eylea Alone Sep 30 2016
Cempra Gets More Good News Sep 30 2016
[$$] Gilead's Growth Tonic Is Elusive, May Have Side Effects Sep 30 2016
Gilead Sciences (GILD) Stock Climbs, Citi: Hepatitis C Sales to Improve Sep 30 2016
Buy These 4 Stocks and Beat Biotech's Slump Sep 30 2016
Two Big Biotechs Flash Bearish Signals Sep 30 2016
Gilead Sciences: Are Hepatitis C Sales Improving? Sep 30 2016
Amgen, Biogen, Gilead Could Spike VA Pricing To Skirt California Measure Sep 29 2016
Gilead May Not Acquire Galapagos, For Now (GILD, GLPG) Sep 28 2016
Four Stellar Stocks to Beat the Biotech Slump Sep 28 2016
Final Trade: BAC, GILD & more Sep 27 2016
Blockbuster biotech deal coming? Sep 27 2016
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis... Sep 27 2016
Gilead 'Paralyzed' On Likely Hepatitis C Share Loss To AbbVie, Merck Sep 27 2016
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis... Sep 27 2016
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis... Sep 27 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK